Prescription Monitoring Act public and stakeholder consultations underway

The provincial government is looking for feedback from the public and stakeholders on the Prescription Monitoring Act, the legislation that informs the operations of the province's Prescription Monitoring Program.

According to a press release issued Friday by the Department of Health, this feedback is part of the operational review of the act necessary after four years since its introduction.

The Department of Health is requesting feedback through electronic and mailed submissions, along with face-to-face consultations with stakeholder groups.

The program allows pharmacists and prescribers to view a patient's prescriptions for specific medications such as Dilaudid, Percocet, Ritalin and Ativan.

The province says the program's importance has grown over the past few years, due to ongoing challenges associated with the growing misuse of medications for pain management, allowing healthcare professionals to safely prescribe drugs which have the potential for misuse, helps prevent and reduce associated harms and supports individuals at risk of addiction.